Achaogen Announces Pricing of Initial Public Offering
March 12, 2014 05:30 ET
|
Achaogen, Inc.
SOUTH SAN FRANCISCO, Calif., March 12, 2014 (GLOBE NEWSWIRE) -- Achaogen, Inc., a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR)...